BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 33692193)

  • 1. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    Allen JD; Ross TM
    J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.
    Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM
    J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
    Allen JD; Ross TM
    Front Immunol; 2021; 12():707339. PubMed ID: 34475872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    Allen JD; Ray S; Ross TM
    PLoS One; 2018; 13(9):e0204284. PubMed ID: 30265682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
    Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses.
    Ge P; Ross TM
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase.
    Skarlupka AL; Zhang X; Blas-Machado U; Sumner SF; Ross TM
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
    Kirchenbaum GA; Carter DM; Ross TM
    J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.
    Kirchenbaum GA; Allen JD; Layman TS; Sautto GA; Ross TM
    J Immunol; 2017 Dec; 199(11):3798-3807. PubMed ID: 29079697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
    Giles BM; Bissel SJ; Dealmeida DR; Wiley CA; Ross TM
    Clin Vaccine Immunol; 2012 Feb; 19(2):128-39. PubMed ID: 22190399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.
    Giles BM; Ross TM
    Vaccine; 2011 Apr; 29(16):3043-54. PubMed ID: 21320540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.